The article discusses the critical collaboration between Chief Human Resource Officers (CHROs) and Chief Information Officers (CIOs) in leading the transition to an AI-first workplace. As AI evolves from being…
Summary This article explores the concept of the “AI Nation” where technological advancements redefine social, economic, and political structures. The author discusses how traditional nation-states are becoming obsolete in the…
Major corporations, like Walmart, are making changes to their diversity initiatives, opting for terms like “belonging” amid political scrutiny. While the language may be softening, the foundational programs around diversity,…
Summary Organisations are increasingly shifting to skills-based hiring, which prioritises demonstrated competencies over traditional metrics such as degrees and job titles. This method not only allows for smarter hiring but…
Summary In a time of heightened political scrutiny, many major U.S. companies, including Walmart, are shifting their language around diversity initiatives. Terms like “belonging” are replacing the traditional diversity, equity,…
Businessolver has unveiled insights from its annual State of Workplace Empathy study, revealing a disturbing link between empathy levels in the workplace and employee wellbeing. The findings highlight stark contrasts…
The latest survey from Wolters Kluwer sheds light on the pressing issue of drug diversion in healthcare settings. With a staggering 81% of healthcare leaders admitting that drug diversion is…
FedEx is gearing up to fully separate its less-than-truckload (LTL) subsidiary, FedEx Freight, by June 2026. In preparation, John A. Smith has been appointed as the new CEO while R.…
In the ever-evolving landscape of cybersecurity, security operations centres (SOCs) are finding themselves overwhelmed by tool sprawl and an avalanche of alerts. This article explores ways to harness AI and…
Genentech has announced updates following the FDA’s Oncologic Drugs Advisory Committee (ODAC) meeting regarding Columvi® (glofitamab-gxbm) in combination with gemcitabine and oxaliplatin (GemOx) for treating relapsed or refractory diffuse large…